Commercial Release of 3D (Breast Tomosynthesis) Biopsy Option Bolsters Hologic's Position as Provider of the Nation's Most Comprehensive Portfolio of Interventional Breast Health Solutions
Hologic, Inc., a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women, recently expanded its array of interventional and imaging solutions for breast health with the launch of a 3D breast biopsy option.
According to the Company, this technology was developed for the Company's Affirm upright breast biopsy guidance system, which is used in conjunction with the Selenia Dimensions 2D and 3D mammography systems.
The Affirm 3D biopsy procedure is designed for the localization and accurate targeting of regions of interest and is especially important for targeting lesions not always detected in 2D images or when using other modalities. Hologic reported that this new biopsy technique has numerous advantages over traditional stereotactic biopsy procedures, including lesion targeting and decreased patient procedure time. In addition, the Affirm system is pre-programmed for use with the Company's Eviva and ATEC vacuum-assisted breast biopsy devices, providing integration of these products.
In June 2013, Magee-Womens Hospital of UPMC became the first facility in the nation to perform a tomosynthesis biopsy, a significant milestone for this new technology, the Company noted. Dr. Jules Sumkin, Chief of Radiology at Magee, performed the Affirm 3D biopsy procedure using the Eviva device. Additional information about this procedure can be found by following this link to the UPMC newsroom.
"The Affirm 3D biopsy option is an important addition to our product portfolio," says Dave Danielsen, Hologic's VP and GM, Breast Imaging. "Physicians now have a new tool, tomosynthesis, to accurately identify regions of interest for biopsy. This addresses an emergent need users of our 3D mammography systems have identified - a biopsy technology that helps them locate lesions seen only on tomosynthesis images, as well as lesions that are better visualized using 3D imaging."
The 3D biopsy option joins Hologic's suite of interventional breast health products, allowing users to depend on a single vendor for the majority of their breast health clinical needs. In addition to the Affirm upright biopsy system, the Company said its MultiCare Platinum biopsy table can be used to perform prone biopsy procedures. The versatile ATEC vacuum-assisted breast biopsy system can be used to perform biopsies under stereotactic, ultrasound, MRI or tomosynthesis guidance using the Company's Eviva or ATEC devices. Hologic also provides a full line of biopsy site markers for use in all breast biopsy modalities.
Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women. The Company operates four core business units focused on diagnostics, breast health, GYN surgical and skeletal health.
((Comments on this story may be sent to firstname.lastname@example.org))